1. Siegel, RL, Miller, KD, Jemal, A Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7–34.
Google Scholar | Crossref | Medline2. Liang, Q, Xu, C, Chen, X, et al. The roles of Mesp family proteins: functional diversity and redundancy in differentiation of pluripotent stem cells and mammalian mesodermal development. Protein Cell 2015; 6: 553–561.
Google Scholar | Crossref | Medline3. Soibam, B, Benham, A, Kim, J, et al. Genome-wide identification of MESP1 targets demonstrates primary regulation over mesendoderm gene activity. Stem Cells 2015; 33: 3254–3265.
Google Scholar | Crossref | Medline4. Bondue, A, Blanpain, C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 2010; 107: 1414–1427.
Google Scholar | Crossref | Medline5. Islas, JF, Liu, Y, Weng, K-C, et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci U S A 2012; 109: 13016–13021.
Google Scholar | Crossref | Medline | ISI6. Chan, SS-K, Shi, X, Toyama, A, et al. Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell 2013; 12: 587–601.
Google Scholar | Crossref | Medline7. Tandon, N, Goller, K, Wang, F, et al. Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis. EBioMedicine 2019; 50: 55–66.
Google Scholar | Crossref | Medline8. Seo, J, Seong, D, Lee, SR, et al. Post-translational regulation of ARF: perspective in cancer. Biomolecules 2020; 10(8): 1143.
Google Scholar | Crossref9. Kamijo, T, Weber, JD, Zambetti, G, et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 1998; 95: 8292–8297.
Google Scholar | Crossref | Medline | ISI10. Pomerantz, J, Schreiber-Agus, N, Liégeois, NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 1998; 92: 713–723.
Google Scholar | Crossref | Medline | ISI11. Horvat, A, Noto, JM, Ramatchandirin, B, et al. Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells. Oncogene 2018; 37: 5054–5065.
Google Scholar | Crossref | Medline12. Wei, J, Noto, JM, Zaika, E, et al. Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut 2015; 64: 1040–1048.
Google Scholar | Crossref | Medline13. Ranjithkumar, R, Alhadidi, Q, Shah, ZA, et al. Tribulusterine containing tribulus terrestris extract exhibited neuroprotection through attenuating stress kinases mediated inflammatory mechanism: in vitro and in vivo studies. Neurochem Res 2019; 44: 1228–1242.
Google Scholar | Crossref | Medline14. Kilany, OE, El-Beltagy, MA, El-Sherbeeny, NA. Tribulus terrestris ameliorates carbon tetrachloride-induced hepatotoxicity in male rats through suppression of oxidative stress and inflammation. Environ Sci Pollut Res 2020; 27: 24967–24981.
Google Scholar | Crossref | Medline15. Al-Bayati, FA, Al-Mola, HF. Antibacterial and antifungal activities of different parts of Tribulus terrestris L. growing in Iraq. J Zhejiang Univ Sci B 2008; 9: 154–159.
Google Scholar | Crossref | Medline16. Roaiah, MF, El Khayat, YI, GamalEl Din, SF, et al. Pilot study on the effect of botanical medicine (Tribulus terrestris) on serum testosterone level and erectile function in aging males with Partial Androgen Deficiency (PADAM). J Sex Marital Ther 2016; 42: 297–301.
Google Scholar | Crossref | Medline17. Shu, CW, Weng, JR, Chang, HW, et al. Tribulus terrestris fruit extract inhibits autophagic flux to diminish cell proliferation and metastatic characteristics of oral cancer cells. Environ Toxicol 2021; 36: 1173–1180.
Google Scholar | Crossref | Medline18. Kim, HJ, Kim, JC, Min, JS, et al. Aqueous extract of Tribulus terrestris Linn induces cell growth arrest and apoptosis by down-regulating NF-κB signaling in liver cancer cells. J Ethnopharmacol 2011; 136: 197–203.
Google Scholar | Crossref | Medline19. Ştefănescu, R, Tero-Vescan, A, Negroiu, A, et al. A comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris L. Biomolecules 2020; 10(5): 752.
Google Scholar | Crossref20. Tu, SP, Jiang, XH, Lin, MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res 2003; 63: 7724–7732.
Google Scholar | Medline | ISI21. Wang, Y-w, Qu, Y, Li, J-f, et al. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity. Clin Cancer Res 2006; 12: 4965–4973.
Google Scholar | Crossref | Medline22. Regalla, K, Lyon, AR, Ingo, V, et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J 2012; 33: 1067–1075.
Google Scholar | Crossref | Medline23. Zhu, M, Cao, L, Xiong, S, et al. Na+/K+-ATPase-dependent autophagy protects brain against ischemic injury. Signal Transduct Target Ther 2020; 5: 55.
Google Scholar | Crossref | Medline24. Carneiro, BA, El-Deiry, WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 2020; 17: 395–417.
Google Scholar | Crossref | Medline25. Sikka, S, Shanmugam, MK, Siveen, KS, et al. Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-κB/STAT3 signaling cascades. Eur J Pharmacol 2021; 906: 174274.
Google Scholar | Crossref | Medline26. Yin, H, Zhang, M-J, An, R-F, et al. Diosgenin derivatives as potential antitumor agents: synthesis, cytotoxicity, and mechanism of action. J Nat Prod 2021; 84: 616–629.
Google Scholar | Crossref | Medline27. Bondue, A, Lapouge, G, Paulissen, C, et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008; 3: 69–84.
Google Scholar | Crossref | Medline | ISI28. Lindsley, RC, Gill, JG, Murphy, TL, et al. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 2008; 3: 55–68.
Google Scholar | Crossref | Medline29. Wu, SM . Mesp1 at the heart of mesoderm lineage specification. Cell Stem Cell 2008; 3: 1–2.
Google Scholar | Crossref | Medline30. Sun, Y, Bilan, PJ, Liu, Z, et al. Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc Natl Acad Sci U S A 2010; 107: 19909–19914.
Google Scholar | Crossref | Medline31. Carrasco-Garcia, E, Moreno, M, Moreno-Cugnon, L, et al. Increased Arf/p53 activity in stem cells, aging and cancer. Aging Cell 2017; 16: 219–225.
Google Scholar | Crossref | Medline32. Vazquez, A, Bond, EE, Levine, AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008; 7: 979–987.
Google Scholar | Crossref | Medline | ISI33. Budanov, AV, Karin, M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008; 134: 451–460.
Google Scholar | Crossref | Medline | ISI34. Patel, A, Soni, A, Siddiqi, NJ, et al. An insight into the anticancer mechanism of Tribulus terrestris extracts on human breast cancer cells. 3 Biotech 2019; 9: 58.
Google Scholar | Crossref | Medline35. Wei, S, Fukuhara, H, Chen, G, et al. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo. Pathobiology 2014; 81: 123–132.
Google Scholar | Crossref | Medline36. Khathayer, F, Ray, SK. Diosgenin as a novel alternative therapy for inhibition of growth, invasion, and angiogenesis abilities of different glioblastoma cell lines. Neurochem Res 2020; 45: 2336–2351.
Google Scholar | Crossref | Medline37. Liu, Y, Zhou, Z, Yan, J, et al. Diosgenin exerts antitumor activity via downregulation of Skp2 in breast cancer cells. Biomed Res Int 2020; 2020: 8072639.
Google Scholar | Medline38. Mao, X-M, Zhou, P, Li, S-Y, et al. Diosgenin suppresses cholangiocarcinoma cells via inducing cell cycle arrest and mitochondria-mediated apoptosis. OncoTargets Ther 2019; 12: 9093–9104.
Google Scholar | Crossref | Medline39. Guo, W, Chen, Y, Gao, J, et al. Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells. Cell Cycle 2019; 18: 1745–1758.
Google Scholar | Crossref | Medline40. Pappas, MP, Peifer, LN, Chan, SSK. Dual TGFβ and Wnt inhibition promotes Mesp1‐mediated mouse pluripotent stem cell differentiation into functional cardiomyocytes. Dev Growth Differ 2020; 62: 487–494.
Google Scholar | Crossref | Medline41. Dinesh Babu, V, Suresh Kumar, A, Sudhandiran, G. Diosgenin inhibits TGF-β1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis. Drug Chem Toxicol 2020; 5: 1–13.
Google Scholar | Crossref42. Zhou, H-T, Yu, X-F, Zhou, G-M. Diosgenin inhibits angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts through regulating the TGF-β1/Smad3 signaling pathway. Mol Med Rep 2017; 15: 2823–2828.
Google Scholar | Crossref | Medline43. Ge, Y, Ding, S, Feng, J, et al. Diosgenin inhibits Wnt/β-catenin pathway to regulate the proliferation and differentiation of MG-63 cells. Cytotechnology 2021; 73: 169–178.
Google Scholar | Crossref | Medline44. Chiapparo, G, Lin, X, Lescroart, F, et al. Mesp1 controls the speed, polarity, and directionality of cardiovascular progenitor migration. J Cell Biol 2016; 213: 463–477.
Google Scholar | Crossref | Medline45. Eskildsen, TV, Ayoubi, S, Thomassen, M, et al. MESP1 knock-down in human iPSC attenuates early vascular progenitor cell differentiation after completed primitive streak specification. Dev Biol 2019; 445: 1–7.
Google Scholar | Crossref | Medline46. Dongre, A, Weinberg, RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 2019; 20: 69–84.
Google Scholar | Crossref | Medline